Estrogen receptor-α variants are associated with lipoprotein size distribution and particle levels in women: The Framingham Heart Study
- 8 July 2005
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 185 (1) , 210-218
- https://doi.org/10.1016/j.atherosclerosis.2005.06.008
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Ischemic heart disease in women and the role of hormone therapyInternational Journal of Cardiology, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Association of Estrogen Receptor-α Gene Polymorphisms With Coronary Artery Disease in Patients With Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Minireview: Genomic Organization of the Human ER Gene Promoter RegionMolecular Endocrinology, 2001
- Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Dissecting the Genetic Architecture of Lipids, Lipoproteins, and ApolipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975